Description
Indication & Scope
JinLiShu® (Amoxicillin and Clavulanate Potassium Tablets) is indicated for the treatment of bacterial infections caused by susceptible β-lactamase-producing organisms, including selected infections of the upper and lower respiratory tract, urinary tract, skin and soft tissues, and middle ear. The combination of amoxicillin with clavulanate extends antibacterial coverage against bacteria that produce β-lactamases capable of inactivating amoxicillin.
- Mechanism: Amoxicillin inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins. Clavulanate inhibits certain bacterial β-lactamases, protecting amoxicillin from enzymatic degradation and restoring its antibacterial activity against susceptible β-lactamase-producing organisms.
- Drug class: Aminopenicillin/β-lactamase inhibitor combination antibiotic.
- Clinical use: Treatment of susceptible bacterial infections, including respiratory tract, urinary tract, skin and soft-tissue, and otitis media infections, according to the approved product labeling.
| Generic Name | Amoxicillin and Clavulanate Potassium Tablets |
| Brand Name | JinLiShu® |
| Ingredient | Amoxicillin and Clavulanate Potassium |
| Dosage Form | Tablet |
| Package | 0.457 g/tablet, 6 tablets/box |
| Conditions Treated | Bacterial infections caused by susceptible β-lactamase-producing organisms, including selected infections of the upper and lower respiratory tract, urinary tract, skin and soft tissues, and middle ear |
| Taboos | Hypersensitivity to penicillins or other beta-lactam antibiotics; previous amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction |
| Place of origin | China |
| Prescription type | Prescription Drug (Rx) |
| Storage Conditions | Store tightly closed in a cool, dry place, protected from light, according to the approved labeling. |
| Manufacturer | Baiyunshan Pharmaceutical General Factory of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval Number | H20041114 |
| Approval Date | September 6, 2024 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Adults and patients weighing ≥40 kg: 1 tablet every 12 hours; dosage may be increased for more severe infections according to physician instructions.
Time: Take at the beginning of a meal to improve gastrointestinal tolerance.
Instructions for use: Swallow with water and complete the prescribed course. Dose adjustment may be required in patients with renal impairment.
Interaction: Allopurinol may increase the risk of skin reactions. Concomitant use with anticoagulants such as warfarin may require monitoring. Probenecid may increase and prolong amoxicillin exposure.
Side effects: Common reactions include diarrhea, nausea, vomiting, and skin rash. Less common or serious reactions include hypersensitivity, hepatic dysfunction, antibiotic-associated colitis, and blood-cell abnormalities.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is JinLiShu®?
JinLiShu® contains amoxicillin and clavulanate potassium, combining a penicillin antibiotic with a β-lactamase inhibitor.
What infections can it treat?
It may be used for susceptible bacterial infections involving the respiratory tract, urinary tract, skin and soft tissues, middle ear, and other sites specified in the approved labeling.
Why is clavulanate added to amoxicillin?
Clavulanate inhibits certain bacterial β-lactamases, helping protect amoxicillin from enzymatic destruction and extending its activity against susceptible β-lactamase-producing bacteria.
How should the tablets be taken?
They should generally be taken at the beginning of a meal and at evenly spaced intervals according to the prescribed regimen.
JinLiShu® | Amoxicillin and Clavulanate Potassium | Bacterial Infections | DengYueRX
INN: Amoxicillin and Clavulanate Potassium
Indications: Bacterial Infections
Dosage Form: Tablet
Strength: 400 mg amoxicillin + 57 mg clavulanate potassium/Tablet
Original price was: $1.58.$1.34Current price is: $1.34.
